Showing results (421-430 of 2,410) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|July 18, 2019
Effectiveness and safety of betrixaban extended prophylaxis for venous thromboembolism compared with standard-duration prophylaxis intervention in acute medically ill patients: a systematic literature review and network meta-analysisVicki Laskier, Holly Guy, Mark Fisher, et al.Journal of Medical Economics|July 18, 2019
Healthcare resource utilization and costs associated with patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive NSCLC in the United StatesCarl Samuelsen, Jonathan Lim, Amanda Golembesky, et al.Journal of Medical Economics|July 13, 2019
Healthcare costs and resource utilization in patients with severe aplastic anemia in the USBeilei Cai, Qayyim Said, Xin Li, et al.Journal of Medical Economics|January 24, 2017
Costs of providing infusion therapy for patients with inflammatory bowel disease in a hospital-based infusion center settingAnita Afzali, Kristine Ogden, Michael L Friedman, et al.Journal of Medical Economics|January 21, 2017
Cost-effectiveness analysis in the Spanish setting of the PEAK trial of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 for first-line treatment of patients with wild-type RAS metastatic colorectal cancerFernando Rivera, Manuel Valladares, Salvador Gea, et al.Journal of Medical Economics|January 19, 2017
Cost-consequence analysis of different active flowable hemostatic matrices in cardiac surgical proceduresD Makhija, M Rock, Y Xiong, et al.Journal of Medical Economics|March 16, 2017
Cost and mortality impact of an algorithm-driven sepsis prediction systemJacob Calvert, Jana Hoffman, Christopher Barton, et al.Journal of Medical Economics|March 28, 2019
Influencing factors of disability among the elderly in China, 2003-2016: application of Bayesian quantile regressionXiaocang Xu, Linhong ChenJournal of Medical Economics|March 19, 2021
The implications of suboptimal year-1 outcomes with disease-modifying therapy in employees with multiple sclerosisCarrie M Hersh, Richard A Brook, Ian A Beren, et al.Journal of Medical Economics|November 9, 2021
Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the NetherlandsJ A Spoorendonk, J-B Briere, K Bowrin, et al.Pageof 241